Researchers sought to determine whether mosunetuzumab would be effective for treating relapsed/refractory FL in patients with 2 or more prior lines of therapy.
Researchers sought to determine whether maribavir would be an effective rescue therapy for patients with cytomegalovirus infection after receiving HCT or solid organ transplants.
